search

All clinical trials

Results 460251-460260 of 470744

Treatment Plan to Provide Expanded Access to Stiripentol for Patients With Dravet Syndrome

Dravet Syndrome

Expanded access to Stiripentol for patients with Dravet Syndrome.

Approved for marketing5 enrollment criteria

Continued Administration of G-202 for One Patient With Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma

Patient with advanced liver cancer (cancer that has spread to other parts of the body) continues to receive the study drug (G-202) even though patient no longer meets the criteria to be a part of the main treatment study. Patient's cancer responded well to receiving G-202 in the main study and will receive G-202 at the same dose given in the main study.

No longer available6 enrollment criteria

Buphenyl Therapy for Byler's Disease

Byler Disease

This is a single patient compassionate use protocol to determine whether Buphenyl (4-phenylbutyrate) will improve the poor bile flow associated with Byler Disease.

No longer available3 enrollment criteria

Open Label Access Study Of Sildenafil In Adult Patients With Pulmonary Arterial Hypertension Completing...

Pulmonary Arterial Hypertension

In an earlier study, sildenafil citrate administered to patients of PAH led to improvement in pulmonary arterial pressure, cardiac output, quality of life, and other parameters as compared to placebo. This protocol provides mechanism for patients who have clinical deterioration on other PAH approved therapies to have access to sildenafil prior to marketing authorization in India.

No longer available5 enrollment criteria

Expanded Access Trial of Belimumab Antibody in RA Patients Who Were Previously Treated Under HGS...

Rheumatoid Arthritis

An expanded access trial of belimumab for named patients who participated in LBRA99.

No longer available7 enrollment criteria

Local Open-Label Access Study For Patients Who Completed A1481244 Study In Brazil

Pulmonary Arterial Hypertension

The purpose of this study is to provide sildenafil therapy to patients who completed the A1481244 study for the treatment of PAH, and reside in Brazilian States where Revatio™ is not supplied by Health Secretary, and are judged by the Investigator to derive clinical benefit from continued treatment with Sildenafil. It will be supplied until patient gets access to Sildenafil through Brazilian State Health Secretary from where patient resides.

No longer available4 enrollment criteria

Expanded Access Protocol for [123I]mIBG for Patients With Known or Suspected Neuroblastoma

Neuroblastoma

GE Healthcare has recently submitted a New Drug Application (NDA) for Iobenguane I 123 Injection ([123I]mIBG (AdreView)) as a diagnostic nuclear imaging agent for the detection of primary or metastatic neuroblastoma and pheochromocytoma. The present protocol establishes an Expanded Access program to provide AdreView to pediatric medical centers and hospitals that treat neuroblastoma patients. AdreView will be provided for use in diagnostic assessment of patients with known or suspected neuroblastoma for whom there is an appropriate clinical indication for [123I]mIBG imaging.

Approved for marketing3 enrollment criteria

Cyclosporine Inhalation Solution (CIS) in Lung Transplant Recipients

Lung Transplant

Currently there are no approved therapies for lung transplant recipients in the United States (US). Treatment with CIS following lung transplantation has previously been demonstrated to result in a clinically meaningful improvement in survival and chronic rejection-free survival compared to placebo, but additional data supporting its use is needed prior to Food and Drug Administration (FDA) approval. This treatment use protocol is a mechanism for providing eligible lung transplant recipients early access to CIS in advance of FDA approval.

No longer available6 enrollment criteria

This is a Multi-center, Single Arm, Open Label Study Intended to Provide Expanded Access to Plerixafor...

Non-Hodgkin's LymphomaHodgkin's Disease1 more

The purpose of this program is to provide expanded access to plerixafor for patients with NHL, HD, or MM who are to receive treatment with an autologous peripheral stem cell transplant.

No longer available27 enrollment criteria

Pulmonary Vein Isolation Outcomes With Fish Oils

Atrial Fibrillation

Fish oil therapy may decrease the incidence of cardiac arrhythmias. This study will test whether pre-treatment with fish oils before catheter ablation of atrial fibrillation decreases the early post operative occurrence of atrial fibrillation.

No longer available9 enrollment criteria
1...460254602646027...47075

Need Help? Contact our team!


We'll reach out to this number within 24 hrs